{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T11:14:18Z","timestamp":1782040458069,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ijantimicag.2007.08.025","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:57:32Z","timestamp":1196960252000},"page":"21-26","source":"Crossref","is-referenced-by-count":43,"title":["Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400mg to healthy volunteers"],"prefix":"10.1016","volume":"31","author":[{"given":"F.M.E.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.G.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.08.025_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0924-8579(99)00046-1","article-title":"Prostatitis: US perspective","volume":"11","author":"Schaeffer","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"JAMA"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2007.08.025_bib3","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1007\/BF01643680","article-title":"Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients","volume":"19","author":"Weidner","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib4","first-page":"258","article-title":"The 2001 Giessen Cohort Study on patients with prostatitis syndrome\u2014an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis","volume":"35","author":"Schneider","year":"2003","journal-title":"Andrologia"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2007.08.025_bib5","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ijantimicag.2004.02.010","article-title":"The role of unusual pathogens in prostatitis syndrome","volume":"24","author":"Skerk","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib6","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1097\/01.ju.0000144291.05839.a0","article-title":"Chronic prostatitis: Charlottesville to Seattle","volume":"172","author":"Krieger","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1439-0272.2003.tb00854.x","article-title":"Chlamydial and ureaplasmal infections in patients with nonbacterial chronic prostatitis","volume":"35","author":"Badalyan","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/14787210.1.2.275","article-title":"Antimicrobial treatment of prostatitis","volume":"1","author":"Wagenlehner","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000019784","article-title":"The role of antibiotics in the treatment of chronic prostatitis: a consensus statement","volume":"34","author":"Bjerklund Johansen","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.8.2.181","article-title":"Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial","volume":"8","author":"MacGowan","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib11","unstructured":"Fachinformation Avalox, Bayer Vital GmbH and Co, Oktober 1999."},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000238605","article-title":"Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue","volume":"34","author":"Kees","year":"1988","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0378-4347(99)00180-2","article-title":"High-performance liquid chromatographic assay of the X-ray contrast agent iopiperidol in plasma and urine of rats and humans","volume":"729","author":"Arbughi","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.45.1.293-297.2001","article-title":"Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers","volume":"45","author":"Naber","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1475-097X.1985.tb00742.x","article-title":"Current status on assessment and measurement of glomerular filtration rate","volume":"5","author":"Brochner-Mortensen","year":"1985","journal-title":"Clin Physiol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0924-8579(00)00362-9","article-title":"Which fluoroquinolones are suitable for the treatment of urinary tract infections?","volume":"17","author":"Naber","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0924-8579(98)00059-4","article-title":"Classification of fluoroquinolones","volume":"10","author":"Naber","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib18","first-page":"455","article-title":"Quinolones: a comprehensive review","volume":"65","author":"Oliphant","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib19","series-title":"12th Scientific Meeting of the European Society of Chemotherapy, 16\u201319 March","first-page":"39","article-title":"Microbial diversity and resistance of pathogens in prostatitis","author":"Lapatschek","year":"2006"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib20","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/AAC.42.8.2060","article-title":"Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects","volume":"42","author":"Stass","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. B","key":"10.1016\/j.ijantimicag.2007.08.025_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/43.suppl_2.83","article-title":"Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man","volume":"43","author":"Stass","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib22","series-title":"Textbook of prostatitis","first-page":"83","article-title":"Antibiotics: basic concepts","author":"Naber","year":"1999"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1179\/joc.2006.18.5.485","article-title":"Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate","volume":"18","author":"Wagenlehner","year":"2006","journal-title":"J Chemother"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2007.08.025_bib24","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1007\/BF01643681","article-title":"Rat model of experimental bacterial prostatitis","volume":"19","author":"Nickel","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/219139a0","article-title":"Diffusion of antibiotics from plasma into prostatic fluid","volume":"219","author":"Winningham","year":"1968","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1439-0272.2003.tb00868.x","article-title":"Antibiotic therapy\u2014rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue","volume":"35","author":"Naber","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib27","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0022-5347(17)35877-9","article-title":"Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750mg","volume":"150","author":"Naber","year":"1993","journal-title":"J Urol"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2007.08.025_bib28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/infdis\/128.Supplement_3.S686","article-title":"The concentration of trimethoprim in prostatic fluid: nonionic diffusion or active transport?","volume":"128","author":"Stamey","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-5347(17)61919-0","article-title":"Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid","volume":"103","author":"Stamey","year":"1970","journal-title":"J Urol"},{"issue":"Suppl. 20","key":"10.1016\/j.ijantimicag.2007.08.025_bib30","first-page":"25","article-title":"Pharmakokinetik der Chinolone","volume":"11","author":"Soergel","year":"2002","journal-title":"Chemotherapie J."},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib31","series-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 17\u201320 September 2000","first-page":"506","article-title":"Limitations in the use of drug cocktails to compare the pharmacokinetics of drugs: ciprofloxacin vs levofloxacin","author":"Bulitta","year":"2000"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/clinids\/4.2.475","article-title":"Prostatitis: review of pharmacokinetics and therapy","volume":"4","author":"Meares","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-5347(17)57333-4","article-title":"The pH of prostatic fluid: a reappraisal and therapeutic implications","volume":"120","author":"Fair","year":"1978","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1464-410X.1974.tb03853.x","article-title":"The response of prostatic fluid pH in inflammation","volume":"46","author":"Blacklock","year":"1974","journal-title":"Br J Urol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib35","first-page":"137","article-title":"Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma","volume":"14","author":"Anderson","year":"1976","journal-title":"Invest Urol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0022-5347(17)57497-2","article-title":"The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis","volume":"119","author":"Pfau","year":"1978","journal-title":"J Urol"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2605.1982.tb00280.x","article-title":"The response of seven prostatic fluid components to prostatic disease","volume":"5","author":"Kavanagh","year":"1982","journal-title":"Int J Androl"},{"key":"10.1016\/j.ijantimicag.2007.08.025_bib38","first-page":"511","article-title":"Change in pH of expressed prostatic secretion during the course of prostatitis","volume":"68","author":"White","year":"1975","journal-title":"Proc R Soc Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907004773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T17:05:21Z","timestamp":1557075921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907004773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0924857907004773"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.08.025","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}